Senior Manager- Clinical Operations at Iterative Health

Cambridge, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Clinical Research, BiotechnologyIndustries

Requirements

At least 8 years experience with phase 2-4 pharma-sponsored clinical trials, including study start-up, CDA, feasibility, regulatory/standard operating procedures, study protocols, and regulations governing clinical research
Experience coordinating, evaluating, and following patients’ participation through clinical trials
Demonstrated ability to manage multiple projects, meet deadlines, manage risk and adjust priorities appropriately in a clinical environment

Responsibilities

Support regular sponsor/CRO/partner level meetings with operational clinical expertise and strengthen stakeholder engagement through building credibility and delivering against sponsor/CRO/partner needs
Ensure data currency to deliver desired insights and metrics to sponsors
Serve as a subject matter expert in clinical research and be a champion for sites
Support study selection, partnering with the Life Science team to review new study protocols and assess fit for our network
Collaborate with manager on protocol feedback to maximize site interest and performance
Manage customer relationships across a diverse group of stakeholders at sponsors, CROs and sites
Act as the voice of the customer and collect feedback to drive continuous improvement across all functional areas within IH
Work closely with sponsor and CRO to find efficiencies to optimize site activation timelines
Communicate risks clearly and recommend resolution strategies, escalating (both internally and externally) as appropriate
Identify blockers and trends, as related to site activations and recruitment and helping cross-functional teams troubleshoot
Facilitate fireside chats and webinars with customers
Travel as needed to conferences, investigator meetings and to support sponsors during site visits

Skills

Clinical Operations

Clinical Trials

Study Management

Site Management

CRO Management

Sponsor Engagement

Research Operations

Strategic Recommendations

AI in Healthcare

Gastroenterology

Hepatology

Iterative Health

AI-driven solutions for gastrointestinal care

About Iterative Health

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve health outcomes for patients worldwide.

Boston, MassachusettsHeadquarters

2017Year Founded

$182.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off

Risks

Competition from tech giants in AI medical imaging threatens Iterative Health's market share.

Rapid expansion and partnerships may strain operational capabilities and resources.

Reliance on AI exposes Iterative Health to potential ethical and regulatory scrutiny.

Differentiation

Iterative Health uses AI to enhance GI care, focusing on colorectal cancer prevention.

Their SKOUT® device aids in adenoma detection, improving diagnostic accuracy in endoscopy.

AI-enabled documentation technology optimizes clinical trials, enhancing research quality and continuity.

Upsides

AI-driven predictive analytics in gastroenterology allow for personalized, effective patient care.

Partnerships with Gastro Health and One GI® expand clinical research capabilities in GI care.

$150M Series B funding accelerates AI innovations, transforming gastroenterology care.

Land your dream remote job 3x faster with AI

Try Jobo Free